After receiving the shift change report about four patients in the cardiac care unit, which patient should the nurse prioritize for assessment?

The correct answer is Choice D.

Choice A rationale: Allergies to shellfish may indicate iodine allergy, relevant for procedures using iodine-based contrast, like PCI. The client’s shellfish allergy must be reported to the PHCP as a precautionary measure to prevent any allergic reaction.

Choice B rationale: Warm sensations during PCI are a common side effect of the contrast dye used in the procedure. This statement does not indicate an immediate concern requiring PHCP notification as it is a standard patient experience.

Choice C rationale: Anxiety in closed spaces, known as claustrophobia, may affect the client's comfort during PCI but can be managed with sedatives. The PHCP should be aware but it’s not as urgent as taking contraindicated medications.

Choice D rationale: Metformin can lead to lactic acidosis, especially when iodine contrast dye is used during PCI. This condition is serious and may result in adverse interactions. The PHCP must be notified immediately.

Choice A rationale
Implementing a smoking cessation program, while beneficial for overall health and cardiovascular risk reduction, is not the primary therapeutic goal for secondary hypertension. Secondary hypertension is high blood pressure caused by an underlying condition. Therefore, the primary goal is to treat the underlying condition.
Choice B rationale
Treating the specific etiological disease is the primary therapeutic goal for secondary hypertension. By treating the underlying cause, blood pressure can often be lowered or returned to normal.
Choice C rationale
Initiating a rapid weight-loss program is not the primary therapeutic goal for secondary hypertension. While weight loss can help lower blood pressure in general, the primary goal in secondary hypertension is to treat the underlying cause.
Choice D rationale
Starting a rigorous exercise regimen, while beneficial for overall health and cardiovascular risk reduction, is not the primary therapeutic goal for secondary hypertension. The primary goal is to treat the underlying condition causing the high blood pressure.